You are here: Industry Insights > Antiviral Drug

News List

IFN-α2b therapy shows promise in patients as potential COVID-19 treatment europeanpharmaceuticalreview
May 20, 2020
A group of researchers has found that IFN-α2b therapy reduced blood levels of IL-6 and C-reactive protein, two inflammatory proteins found in COVID-19 patients.
BioMed X Launches Rapid Antiviral Response Platform contractpharma
May 14, 2020
Aims to develop ultrafast new antiviral drug discovery, development and mass-manufacturing tools for rapid scale-up of new medications.
New triple antiviral drugs combo shows promise against COVID-19: Study expresspharma
May 11, 2020
Treatment involving a combination of the drugs interferon beta-1b, plus antiviral therapy lopinavir-ritonavir and ribavirin, is better at reducing the viral load.
Fujifilm Boosts Production of Avigan Tablet for COVID-19 contractpharma
April 16, 2020
Expands manufacturing capacity at Fujifilm Toyama Chemical to increase production of its influenza antiviral drug.
AIkido Pharma Inks Exclusive License for Antiviral Drug Platform contractpharma
April 15, 2020
Pan-viral inhibitory compound with efficacy against multiple viral pathogens including Influenza, SARS-COV, MERS-COV, Ebola and Marburg virus.
University Hospitals among first in nation to test investigational antiviral drug against COVID-19 prnewswire
March 25, 2020
University Hospitals has secured two clinical trials that will provide the investigational antiviral drug remdesivir to hospitalized adults with a pneumonia ...
Lasa & ICT explore Favipiravir therapy to fight Covid 19 expresspharma
March 18, 2020
Favipiravir is an antiviral drug and is a promising antidote for the treatment of Coronavirus disease (Covid-19).
Which Will Claim the Real "Magic Medicine" Among 3 "Specific Medicines" against Novel Coronavirus Pneumonia PharmaSources/Mi Ling
February 25, 2020
Challenge Contest of "Specific Medicines" against Novel Coronavirus Pneumonia - Which Will Claim the Real "Magic Medicine" in Such 1/3 Competition?
Experimental antiviral Drug Remdesivir recognized as potential treatment for 2019-nCov PharmaSources
February 10, 2020
Remdesivir, an experimental antiviral drug, has been recognized as a potential treatment against the 2019 novel-Coronavirus (2019-nCov) recently outbreaks in China and around the world.
GS-5734 inhibits a range of emerging coronaviruses europeanpharmaceuticalreview
March 13, 2018
Researchers report on GS-5734, a promising experimental broad-spectrum antiviral drug…